Polyphosphazene Vaccine Delivery Vehicles: State of Development and Perspectives

Polyphosphazenes for Biomedical Applications

Volumn , Issue , 2008, Pages 45-63

  Andrianov, Alexander K ^a  

^a Apogee Technology Inc   (United States)

Author keywords

PCPP and process controls; Polyphosphazene vaccine delivery vehicles; Vaccine delivery and immunomodulation

Indexed keywords

EID: 84889407243     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470478882.ch3     Document Type: Chapter

References (45)

1. Singh, M., ed. Vaccine Adjuvants and Delivery Systems. Wiley-Interscience, Hoboken, NJ, 2006, p. 449.
2. Andrianov, A.K., Marin, A., Chen, J. Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene]. Biomacromolecules, 2006, 7(1):394-399.
3. Andrianov, A.K., Marin, A., Roberts, B.E. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Biomacromolecules, 2005, 6(3):1375-1379.
4. Andrianov, A.K., Sargent, J.R., Sule, S.S., Le Golvan, M.P., Woods, A.L., Jenkins, S.A., Payne, L.G. Synthesis, physico-chemical properties and immunoadjuvant activity of water-soluble phosphazene polyacids. J Bioact Compat. Polym, 1998, 13(4):243-256.
5. Mutwiri, G., Benjamin, P., Soita, H., Townsend, H., Yost, R., Roberts, B., Andrianov, A.K., Babiuk, L.A. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens. Vaccine, 2007, 25(7):1204-1213.
6. Payne, L.G., Jenkins, S.A., Andrianov, A., Roberts, B.E. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. Pharm. Biotechnol., 1995, 6:473-493.
7. Payne, L.G., Jenkins, S.A., Woods, A.L., Grund, E.M., Geribo, W.E., Loebelenz, J.R., Andrianov, A.K., Roberts, B.E. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine, 1998, 16(1):92-98.
8. Lu, Y., Salvato, M.S., Pauza, C.D., Li, J., Sodroski, J., Manson, K., Wyand, M., Letvin, N., Jenkins, S., Touzjian, N., Chutkowski, C., Kushner, N., LeFaile, M., Payne, L.G., Roberts, B. Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 1996, 12(2):99-106.
9. Payne, L.G., Van Nest, G., Barchfeld, G.L., Siber, G.R., Gupta, R.K., Jenkins, S.A. PCPP as a parenteral adjuvant for diverse antigens. Dev. Biol. Stand., 1998, 92:79-87.
10. Payne, L.G., Jenkins, S.A., Andrianov, A., Langer, R., Roberts, B.E. Xenobiotic polymers as vaccine vehicles. Ad. Exp. Med. Biol., 1995, 371(B):1475-1480.
11. Andrianov, A.K. Polyphosphazenes as vaccine adjuvants. In Singh, M. ed. Vaccine Adjuvants and Delivery Systems. Wiley, Hoboken, NJ, 2007, p. 355-378.
12. Andrianov, A.K., Chen, J. Polyphosphazene microspheres: preparation by ionic complexation of phosphazene polyacids with spermine. J. Appl. Polym. Sci, 2006, 101(1):414-419.
13. Andrianov, A.K., Chen, J., Payne, L.G. Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions. Biomaterials, 1998, 19(1-3):109-115.
14. Andrianov, A.K., Chen, J., Sule, S.S., Roberts, B.E. Ionically cross-linked polyphosphazene microspheres. ACS Symp. Ser., 2000, 752:395-406.
15. Andrianov, A.K., Payne, L.G. Polymeric carriers for oral uptake of microparticulates. Adv. Drug Deliv. Rev., 1998, 34(2-3):155-170.
16. Andrianov, A.K., Payne, L.G. Protein release from polyphosphazene matrices. Adv. Drug Deliv. Rev., 1998, 31(3):185-196.
17. Andrianov, A.K., Marin, A., Peterson, P., Chen, J. Fluorinated polyphosphazene polyelectrolytes. J. Appl. Polym. Sci., 2007, 103(1):53-58.
18. Andrianov, A.K., Chen, J., LeGolvan, M.P. Poly(dichlorophosphazene) as a precursor for biologically active polyphosphazenes: synthesis, characterization, and stabilization. Macromolecules, 2004, 37(2):414-420.
19. Andrianov, A.K., LeGolvan, M.P. Characterization of poly[di(carboxylatophenoxy)-phosphazene] by an aqueous gel permeation chromatography. J. Appl. Polym. Sci., 1996, 60(12):2289-2295.
20. Andrianov, A.K., Svirkin, Y.Y., LeGolvan, M.P. Synthesis and biologically relevant properties of polyphosphazene polyacids. Biomacromolecules, 2004, 5(5):1999-2006.
21. Andrianov, A.K., Marin, A. Degradation of polyaminophosphazenes: Effects of hydrolytic environment and polymer processing. Biomacromolecules, 2006, 7(5): 1581-1586.
22. Andrianov, A.K., Marin, A., Peterson, P. Water-soluble biodegradable polyphosphazenes containing N-ethylpyrrolidone groups. Macromolecules, 2005, 38(19): 7972-7976.
23. Andrianov, A.K., Payne, L.G., Visscher, K.B., Allcock, H.R., Langer, R. Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres. J. Appl. Polym. Sci., 1994, 53(12):1573-1578.
24. Andrianov, A.K. Design and synthesis of functionalized polyphosphazenes with immune modulating activity. PMSE Prepr., 2003, 88.
25. Andrianov, A.K. Water-soluble biodegradable polyphosphazenes: emerging systems for biomedical applications. Polym. Prepr, 2005, 46(2):715.
26. Andrianov, A.K., Marin, A. Immunostimulating polyphosphazene compounds, us2006/0193820, 2006.
27. Wu, J.Y., Wade, W.F., Taylor, R.K. Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice. Infecti. Immun., 2001, 69(12):7695-7702.
28. Mapletoft, J.W., Oumouna, M., Kovacs-Nolan, J., Latimer, L., Mutwiri, G., Babiuk, L.A., van Drunen Littel-van den Hurk, S. Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection. J. Gen. Virol., 2008, 89:250-260.
29. McNeal, M.M., Rae, M.N., Ward, R.L. Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus. Vaccine, 1999, 17(11-12):1573-1580.
30. Kabanov, A.V. From synthetic polyelectrolytes to polymer-subunit vaccines. Pure Appl. Chem., 2004, 76(9):1659-1677.
31. Kabanov, A.V. Polymer genomics: an insight into pharmacology and toxicology of nanomedicines. Adv. Drug Deliv. Rev., 2006, 58(15):1597-1621.
32. Kabanov, A.V., Batrakova, E.V., Sherman, S., Alakhov, V.Y. Polymer genomics. Adv. Polym. Sci., 2006, 173-198.
33. Cairo, C.W., Gestwicki, J.E., Kanai, M., Kiessling, L.L. Control of multivalent interactions by binding epitope density. J. Am. Chem. Soc., 2002, 124(8): 1615-1619.
34. Mutwiri, G., Gerdts, V., Lopez, M., Babiuk, L.A. Innate immunity and new adjuvants. OIE Rev Sci Tech., 2007, 26(1):147-156.
35. Bouveret Le Cam, N.N., Ronco, J., Francon, A., Blondeau, C., Fanget, B. Adjuvants for influenza vaccine. Res. Immunol., 1998, 149(1):19-23.
36. Gilbert, P.B., Chiu, Y.L., Allen, M., Lawrence, D.N., Chapdu, C., Israel, H., Holman, D., Keefer, M.C., Wolff, M., Frey, S.E. Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAIDsponsored phase I and II clinical trials. Vaccine, 2003, 21(21-22):2933-2947.
37. Kim, J.H., Kirsch, E.A., Gilliam, B., Michael, N.L., VanCott, T.C., Ratto-Kim, S., Cox, J., Nielsen, R., Robb, M.L., Caudrelier, P., El Habib, R., McNeil, J. A phase I, open label, dose ranging trial of the Pasteur Merieux Connaught (PMC) oligomeric HIV-1 Gp160mn/LAI-2 vaccine in HIV seronegative adults. Abstracts of the 37th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, 1999.
38. Thongcharoen, P., Suriyanon, V., Paris, R.M., Khamboonruang, C., de Souza, M.S., Ratto-Kim, S., Karnasuta, C., Polonis, V.R., Baglyos, L., El Habib, R. A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. J. Acquir. Immune Defic. Syndr, 2007, 46(1):48.
39. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, and butylparaben. J. Am. Coll. Toxicol., 1984, 3(5): 145-209.
40. Soni, M.G., Burdock, G.A., Taylor, S.L., Greenberg, N.A. Safety assessment of propyl paraben: a review of the published literature. Food Chem. Toxicol., 2001, 39(6):513-532.
41. Soni, M.G., Carabin, I.G., Burdock, G.A. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food Chem. Toxicol., 2005, 43(7):985-1015.
42. Andrianov, A.K., LeGolvan, M.P., Sule, S.S., Payne, L.G. Degradation of poly [di(carboxylatophenoxy)phosphazene] in aqueous solution. In Polymeric Materials Science and Engineering. Proceedings of the ACS Division of Polymeric Materials Science and Engineering, San Francisco, 1997.
43. Allcock, H.R. Chemistry and Applications of Polyphosphazenes. Wiley, Hoboken, NJ, 2002, p. 725.
44. Andrianov, A.K., Marin, A., Chen, J., Sargent, J., Corbett, N. Novel route to sulfonated polyphosphazenes: single-step synthesis using noncovalent protection of sulfonic acid functionality. Macromolecules, 2004, 37(11):4075-4080.
45. Allcock, H.R., Kwon, S. An ionically cross-linkable polyphosphazene: poly[bis (carboxylatophenoxy)phosphazene] and its hydrogels and membranes. Macromolecules, 1989, 22(1):75-79.